GL1X · GenesisL1 explorer

MolNFT v1 · #286821 · protein

AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (Q7N869)

Q7N869: “AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (Q7N869)”. 2 pockets (best druggability 0.67). MolNFT v1 #286821 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q7N869
Type
protein
Length
263 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xAcde31F011Da58757068544bc9B82f37d30d5Bf0
Molecule
3-methyl-2-oxobutanoate hydroxymethyltransferase
UniProt
Q7N869
Pockets
2 · best druggability 0.67

Structure

1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-methyl-2-oxobutanoate hydroxymethyltransferaseprotein26346% helix, 14% strandQ7N869

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12150.670.8432empty
21140.390.7422empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.